Monthly Archives: September 2009

Pharma M and As sounding death knell for low-cost drugs?

September 29th, 2009|

It began in 2006, with the Hyderabad based Matrix Labs becoming a subsidiary of a US company. Then it was Ranbaxy Labs' turn to get sold to a Japanese major. Vaccine player Shantha Biotech followed suit in July this year by being bought over by a French company.

Pharma industry steps up recruitment 5 times

September 29th, 2009|

At a time when global multinational drug makers are slashing their workforces to reduce costs, their Indian counterparts are on a hiring spree.

Indias genetic divide may hit pharma cos R and D plans

September 29th, 2009|

Global pharma firms making drugs for the Indian market may have to review their discovery and development programme, following a path-breaking discovery by top Indian and American scientists that India is genetically not a single large population.

Wockhardt gets US nod for Tamsulosin capsules

September 29th, 2009|

Pharma major Wockhardt Tuesday got the US Food and Drug Administration's (USFDA) tentative approval for marketing Tamsulosin Hydrochloride capsules.

Pharmac India 2009 to be held in Ahmedabad from Nov 7 to 9

September 29th, 2009|

The Indian Drug Manufacturers Association Gujarat State Board (IDMA -GSB) is organising India's largest pharma & healthcare exhibition 'Pharmac India 2009' in Ahmedabad from November 7 to 9. While Pharmexcil is the co-organiser of the event, it is supported by Federation of Pharma Entrepreneurs (FOPE), Sabarkantha District Drug Manufacturers Association, BDMA and Rajasthan Pharmaceutical Manufacturers Association.

IPA(MP) to organize seminar on enforcement and implications of Spurious Drugs Act

September 29th, 2009|

The Indian Pharmaceutical Association, Madhya Pradesh State Branch, Indore (IPA, MPSB) is organizing a one-day seminar on 'Drugs and Cosmetics (Amendment) Act, 2008: Enforcement, implications and provisions' on October 3 at Hotel Sayaji in Indore.

Sanofi-Aventis scans India for acquisitions

September 28th, 2009|

Sanofi-Aventis, the $42-billion French drug maker, which bought companies in Brazil, Mexico, and the home-grown Shanta Biotech this year, has sent a delegation to India to finalise another target for acquisition in a market that is estimated to be worth more than $17 billion and growing, two persons familiar with the matter said.

Pharma exports up 29 pc to US dollar 9.35 bn

September 28th, 2009|

India's exports of drugs, pharmaceuticals and fine chemicals grew by 29 per cent last fiscal to Rs.39,538 crore (around $9.35 billion) compared to the previous fiscal, Commerce and Industry Minister Anand Sharma said in the Indo- Africa Pharma Business Meet.

Wockhardt is top Indian pharma patentee bags government award

September 28th, 2009|

Pharmaceutical and biotechnology major Wockhardt Limited has received the Government of India award for the maximum number of patents filed and granted in India by any pharmaceutical company.

Abbott to acquire Solvay Pharmaceuticals for US dollar 6.6 bn

September 28th, 2009|

American healthcare major Abbott Laboratories today said it will buy pharma business of Belgium-based Solvay Group for USD 6.6 billion.

Growing pharma market makes India a clinical trial destination: Report

September 28th, 2009|

The domestic pharmaceutical market is expected to triple to $20 billion by 2015 from the current $7 billion and move into the world’s top 10 markets.

Mega deals boost pharma in crisis

September 14th, 2009|

Following the collapse of Lehman Brothers and the global meltdown, pharmaceuticals is perhaps the only sector globally which withstood it all, announcing a slew of deals month after month.

Glenmark plans cancer drug unit in Argentina

September 14th, 2009|

Mid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina to strengthen its presence in the global cancer drug market that is expected to grow by nearly 80% to $85 billion in four years.

Reddy’s gets US FDA nod, launches Starlix clone

September 14th, 2009|

The strategy of the Hyderabad-based pharma major Dr Reddy's Laboratories' (DRL) to approach the US market with a series of gambles rather than on one major upside is paying dividends.

Biocon, Amylin Pharma tie up to develop new diabetes drug

September 14th, 2009|

Biocon Ltd said it had tied up with Amylin Pharmaceuticals, Inc. to jointly develop, make and market a novel peptide drug to treat diabetes.

Lotus aims to roll out 4 more centres next year

September 10th, 2009|

After setting up its centre in Chennai recently, Bangalore-based Lotus Clinical Research Academy (LCRA) is looking at four new cities to set up its centre next year. The academy is planning to set up its centre in Ahmedabad, besides Delhi, Mumbai and Hyderabad.

Pfizer plans major push into generics

September 10th, 2009|

Pfizer Ltd, the Indian subsidiary of the world’s largest drug maker Pfizer Inc., is making an aggressive play in the Indian generics or off-patent drugs market.

Mid-cap pharma firms focus on LatAm market

September 10th, 2009|

Lupin and Glenmark Pharmaceuticals are leading Indian mid-cap drug makers in exploiting rising demand for medicines in South American nations, such as Brazil and Argentina, even as competition and rules intensify in the developed markets of the US and Europe.

Yakult Danone India Pvt Ltd expands national footprint Launches Worlds No 1 Probiotic drink

September 9th, 2009|

Brand ambassador Kajol Devgan promotes the kiss of good health. Expanding its footprint in India, Yakult Danone India (P) Ltd. announced its expansion by launching Yakult, a global probiotic health drink in the city today.

2009 India Excellence in Healthcare Awards

September 7th, 2009|

Frost & Sullivan, for the first time, hosted ‘2009 India Excellence in Healthcare Awards” on 4, September, 2009 at Intercontential- The Lalit, Mumbai.